Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Covidien plc    COV   IE00B68SQD29


Delayed Quote. Delayed Nyse - 09/18 04:00:14 pm
91.6 USD   +0.49%
1d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
1d ago COVIDIEN : SonicisionTM Portfolio Expansion Enables Surgeons to Choose Idea..
2d ago COVIDIEN : Announces Dividend Increase
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Covidien plc : Covidien Recalls Duet TRS Staplers on Anatomical Injury Potential

08/22/2012 | 09:55am US/Eastern
   By Saabira Chaudhuri 

Covidien PLC (COV) is voluntarily recalling its Duet TRS staplers after receiving one report that links the tissue reinforcement material to a post-operative injury after abdominal surgery.

Launched in 2009, the product is a tissue reinforcement system to support staple lines. To date, Covidien has sold more than 540,000 worldwide.

Covidien on Wednesday said it has stopped manufacturing the units, after concluding that Duet TRS may have the potential to injure adjacent anatomical structures, which may result in life threatening post-operative complications.

The affected product codes range between 4535 to 6048A.

The most recent recall is in addition to one unveiled in January relating to the contraindication of the device in the thoracic cavity. At that time, Covidien received reports of 13 serious injuries and three fatalities following the application of Duet TRS in the thoracic cavity.

On Wednesday, the company said all Duet TRS products can be returned by emailing or calling 1-800-722-8772, option 1, to obtain a return goods authorization prior to returning the affected units.

People can report adverse events or quality problems related to the product by calling or emailing the Food and Drug Administration's MedWatch Adverse Event Reporting program.

Write to Saabira Chaudhuri at

Subscribe to WSJ:

Recommend :
React to this article
Latest news on COVIDIEN PLC
1d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
1d ago COVIDIEN : SonicisionTM Portfolio Expansion Enables Surgeons to Choose Ideal Cor..
2d ago COVIDIEN : Announces Dividend Increase
3d ago Roche's $8 billion InterMune buy not a signal for more big deals
4d ago Danaher to buy Nobel Biocare for $2.2 billion
4d ago Danaher to buy Nobel Biocare for $2.2 billion
4d ago COVIDIEN : Announces Start of Enrollment in Two Neurovascular Clinical Trials
4d agoDJDanaher Buys Nobel Biocare in $2.1 Billion Cash Deal
09/05 COVIDIEN : Upcoming Conferences, Dividends, Regulatory Disclosures, and Acquisit..
08/28 COVIDIEN : Acquires Venous Disease Treatment Developer Sapheon, Inc.
Duration : Period :
Covidien plc Technical Analysis Chart | COV | IE00B68SQD29 | 4-Traders
Income Statement Evolution
Covidien plc : Income Statement Evolution
More Financials
Dynamic quotes